Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

COVID-19 Update: White House Plan for Vaccinating Children

By Yvonne Puig (US), Daphne Calderon (US) & Hannah Putnam (US) on October 21, 2021
Email this postTweet this postLike this postShare this post on LinkedIn

On Wednesday, October 20, 2021, the White House discussed in a press conference its plan for vaccinating children aged 5 through 11. The White House stated it has worked closely with “governors, pediatricians, pharmacies, community health centers, rural health centers, and other vaccine providers” in preparation of a vaccine rollout. Of course, these plans are pending FDA and CDC authorization.

The White House highlighted four points of progress across “a few key operational fronts” related to a vaccine rollout for children:

(1) The United States has secured a vaccine supply sufficient to vaccinate every child aged 5 through 11. And as soon as it is approved by the FDA, the Administration will begin shipping millions of doses nationwide that are tailored for children’s needs.

(2) More than 25,000 pediatricians, family doctors, and other primary care providers are enrolled to administer vaccines to children. Children in underserved communities have also been accounted for and there are hundreds of community health care centers across the nation ready to begin when appropriate.

(3) The White House is working with state and local education leaders to bring vaccination clinics directly to schools, including the provision of on-site clinics.

(4) Finally, the White House is dedicated to disseminating factual information about the vaccine for parents to make informed decisions based on the right choice for each child. This includes by “empowering messengers [parent’s] trust, such as local pediatricians and family doctors.”

Norton Rose Fulbright lawyers will continue to provide relevant updates for healthcare providers on the Health Law Pulse during the COVID-19 public health crisis.

Photo of Yvonne Puig (US) Yvonne Puig (US)

US Head of Life Sciences and Healthcare Yvonne Puig has a substantial commercial litigation practice in both state and federal courts. She represents hospitals, HMOs, managed care organizations, medical schools and other institutional health care providers and educational services companies. A partner in…

US Head of Life Sciences and Healthcare Yvonne Puig has a substantial commercial litigation practice in both state and federal courts. She represents hospitals, HMOs, managed care organizations, medical schools and other institutional health care providers and educational services companies. A partner in Norton Rose Fulbright’s Austin office, Yvonne’s practice involves commercial and health care litigation, antitrust, regulatory and compliance advice, crisis management, staff privileges, exclusive contracting and administrative law.

Read more about Yvonne Puig (US)Email
Show more Show less
Photo of Daphne Calderon (US) Daphne Calderon (US)
Read more about Daphne Calderon (US)Email
Photo of Hannah Putnam (US) Hannah Putnam (US)
Read more about Hannah Putnam (US)Email
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Health Law Pulse
  • Organization:
    Norton Rose Fulbright
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo